Product Information

BUDESONIDE DR 3 MG CAPSULE is a generic product labeled by American Health Packaging, priced at $0.5193 per EA under NDC 60687059632. Its NADAC has been published 290 times since May 5, 2021.

FDA first approved this application on May 4, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUDESONIDE DR 3 MG CAPSULE

Budesonide
$0.5193per EA

Strength

3 mg/1

NDC

60687059632

Classification

Generic

Dosage Form

CAPSULE, COATED PELLETS

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

BUDESONIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA206134

FDA Approved

5/4/2017

TE Code

AB

On Market Since

3/9/2021

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for BUDESONIDE DR 3 MG CAPSULE has been published 290 times since May 5, 2021, and over the history we have for it it has declined 46.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5193 per EA
All-time high$1.0435 (Jan 12, 2022)
All-time low$0.4242 (Nov 20, 2024)
52-week high$0.5230
52-week low$0.4975
Median price$0.6261
Average price$0.6588
Largest weekly change+27.0% (Jun 19, 2024)
Weeks tracked290
Tracking sinceMay 5, 2021

Price History

1W

+0.2%

1M

+0.2%

3M

+4.1%

6M

-0.3%

1Y

-0.5%

3Y

-19.9%

5Y

-41.6%

All

-46.8%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUDESONIDE DR 3 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for BUDESONIDE DR 3 MG CAPSULE, manufactured by American Health Packaging, is $0.5193 per EA (NDC 60687059632), effective Nov 18, 2026.

How has the price of BUDESONIDE DR 3 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for BUDESONIDE DR 3 MG CAPSULE has declined 46.8%. It has been tracked across 290 weekly CMS publications since May 5, 2021.

What are the highest and lowest recorded NADAC prices for BUDESONIDE DR 3 MG CAPSULE?

Since May 5, 2021, the NADAC for BUDESONIDE DR 3 MG CAPSULE has ranged from a low of $0.4242 (Nov 20, 2024) to a high of $1.0435 (Jan 12, 2022), with a median of $0.6261 per EA.

Are there cheaper alternatives to BUDESONIDE DR 3 MG CAPSULE?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUDESONIDE EC 3 MG CAPSULE, is $0.5154 per EA — about 1% below BUDESONIDE DR 3 MG CAPSULE.

Who manufactures BUDESONIDE DR 3 MG CAPSULE?

BUDESONIDE DR 3 MG CAPSULE (NDC 60687059632) is labeled by American Health Packaging, and CMS classifies it as a generic product.